TC BioPharm Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TC BioPharm Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10954
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TC BioPharm Ltd (TC BioPharm) is an immunotherapy company that develops cell based products for treatment of cancer and viral infection. The company pipeline products are intended for the treatment of ovarian cancer, breast cancer and epidermolysisbullosa related disease, among others. It works in collaboration with various cancer centers in Glasgow, Edinburgh and Southampton; in the UK to develop ImmuniCell, among others. TC BioPharm provides clinical manufacturing facility which is located in Holytown, Scotland, the UK. The company operates in the UK. TC BioPharm is headquartered in Edinburgh, the UK.

TC BioPharm Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TC BioPharm Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TC BioPharm Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
TC BioPharm Raises More Than USD7.8 Million in Series A Financing Round 11
TC BioPharm Raises USD1.1 million in Venture Financing 12
TC BioPharm Raises USD0.4 Million Through Seed Funding 13
TC BioPharm Raises USD2 Million in Venture Financing 14
Partnerships 15
TC BioPharm and Scotia Biologics Enter into Agreement 15
TC Biopharm and Nipro Enter into Co-Development Partnership 16
TC BioPharm Enters into Co-Development Agreement with Sistemic 17
Licensing Agreements 18
bluebird bio Enters into Licensing Agreement with TC BioPharm 18
TC BioPharm Enters into Licensing Agreement with University College London 19
TC BioPharm Enters into Licensing Agreement with Medinet 20
TC BioPharm Ltd – Key Competitors 21
TC BioPharm Ltd – Key Employees 22
TC BioPharm Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Strategy And Business Planning 24
Feb 14, 2018: Scottish Immunotherapy Company TC Biopharm Opens First Overseas Office in Japan 24
Product News 25
08/02/2017: TCB Selected For EU Horizon 2020 Funding to Progress Novel, Mass-Market Cell Therapies to Clinical Trial 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Key Facts 2
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TC BioPharm Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TC BioPharm Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
TC BioPharm Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TC BioPharm Raises More Than USD7.8 Million in Series A Financing Round 11
TC BioPharm Raises USD1.1 million in Venture Financing 12
TC BioPharm Raises USD0.4 Million Through Seed Funding 13
TC BioPharm Raises USD2 Million in Venture Financing 14
TC BioPharm and Scotia Biologics Enter into Agreement 15
TC Biopharm and Nipro Enter into Co-Development Partnership 16
TC BioPharm Enters into Co-Development Agreement with Sistemic 17
bluebird bio Enters into Licensing Agreement with TC BioPharm 18
TC BioPharm Enters into Licensing Agreement with University College London 19
TC BioPharm Enters into Licensing Agreement with Medinet 20
TC BioPharm Ltd, Key Competitors 21
TC BioPharm Ltd, Key Employees 22
TC BioPharm Ltd, Other Locations 23

List of Figures
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TC BioPharm Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TC BioPharm Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[TC BioPharm Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GBST Holdings Limited (GBT):企業の財務・戦略的SWOT分析
    GBST Holdings Limited (GBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Consolidated Edison Company of New York, Inc.-エネルギー分野:企業M&A・提携分析
    Summary Consolidated Edison Company of New York, Inc. (CECONY), a subsidiary of Consolidated Edison, Inc. is an energy utility that generates, transmits and distributes electricity; supplies natural gas; and generates and supplies steam. The company provides electricity and related services in New Y …
  • Balfour Beatty plc:企業の戦略・SWOT・財務情報
    Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report Summary Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Natera Inc (NTRA):企業の製品パイプライン分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers Panorama, a non-invasive prenatal screening test that analyzes baby's DNA through a simple blood dra …
  • Vast Resources Plc:企業の戦略・SWOT・財務分析
    Vast Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Vast Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Net One Systems Co Ltd (7518):企業の財務・戦略的SWOT分析
    Net One Systems Co Ltd (7518) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Entertainment One Ltd.
    Entertainment One Ltd. - Strategy, SWOT and Corporate Finance Report Summary Entertainment One Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • DCP Midstream LP (DCP):企業の財務・戦略的SWOT分析
    DCP Midstream LP (DCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Lattice Semiconductor Corp (LSCC):企業の財務・戦略的SWOT分析
    Lattice Semiconductor Corp (LSCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Petroleos Mexicanos:企業の戦略・SWOT・財務情報
    Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report Summary Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Solstad Farstad ASA (SOFF):石油・ガス:M&Aディール及び事業提携情報
    Summary Solstad Farstad ASA (Solstad), formerly Solstad Offshore ASA is an oil and gas company that provides vessel operation solutions. The company offers carbon footprint, climate neutral network, offshore shipping, green operations, and rainforest protection, documentation programs, and others. I …
  • EnCana Corporation:企業の戦略・SWOT・財務情報
    EnCana Corporation - Strategy, SWOT and Corporate Finance Report Summary EnCana Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • TUV Rheinland AG:企業の戦略的SWOT分析
    TUV Rheinland AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Molex LLC:企業のM&A・事業提携・投資動向
    Molex LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Molex LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Emami Limited:戦略・SWOT・企業財務分析
    Emami Limited - Strategy, SWOT and Corporate Finance Report Summary Emami Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Publix Super Markets, Inc.:企業の戦略・SWOT・財務分析
    Publix Super Markets, Inc. - Strategy, SWOT and Corporate Finance Report Summary Publix Super Markets, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ferguson Enterprises Inc:企業の戦略的SWOT分析
    Ferguson Enterprises Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Expro Holdings UK 2 Limited:企業の戦略的SWOT分析
    Expro Holdings UK 2 Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Mitsubishi Chemical Holdings Corporation:企業の戦略・SWOT・財務分析
    Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Chemical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Lario Oil & Gas Company:石油・ガス:M&Aディール及び事業提携情報
    Summary Lario Oil & Gas Company (Lario Oil & Gas) is an oil and gas exploration and production company that explores and produces oil and gas properties. The company offers services such as discovering reserves organically from geologic thesis, drill-bit, field delineation, and land acquisition and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆